<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is 1 of the most common causes of <z:hpo ids='HP_0000554'>uveitis</z:hpo> in the Eastern world </plain></SENT>
<SENT sid="1" pm="."><plain>Its common ocular complications are <z:hpo ids='HP_0000554'>uveitis</z:hpo>, <z:hpo ids='HP_0000518'>cataract</z:hpo>, and obliteration of <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels </plain></SENT>
<SENT sid="2" pm="."><plain>Phacoemulsification with intraocular lens (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e>) implantation in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is known to be a safe procedure </plain></SENT>
<SENT sid="3" pm="."><plain>We managed a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease who had aggravated <z:hpo ids='HP_0000554'>uveitis</z:hpo> and opacification of a hydrophilic acrylic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e> (ACRL-C160, Ophthalmed) 4 months after <z:hpo ids='HP_0000518'>cataract</z:hpo> surgery </plain></SENT>
<SENT sid="4" pm="."><plain>Recalcitrant <z:hpo ids='HP_0000554'>uveitis</z:hpo> despite maximum tolerable medication and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e> opacification with vitreous opacity necessitated an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e> exchange and trans pars plana vitrectomy </plain></SENT>
<SENT sid="5" pm="."><plain>After the procedure, the eye became quiescent </plain></SENT>
<SENT sid="6" pm="."><plain>However, the visual acuity was 20/200 because of the obliteration of <z:chebi fb="46" ids="15035">retinal</z:chebi> vessels </plain></SENT>
</text></document>